Aadi Bioscience, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aadi Bioscience, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Aadi Bioscience, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $982K, a 27.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $982K -$367K -27.2% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $1.08M -$360K -25.1% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.17M -$353K -23.2% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $1.26M -$313K -19.9% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $1.35M -$304K -18.4% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.44M +$919K +177% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $1.52M +$965K +173% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $1.57M +$976K +163% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.65M +$1.64M +17388% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $518K +$481K +1294% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $557K +$438K +368% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $597K +$507K +565% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $9.45K -$105K -91.8% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $37.2K -$102K -73.2% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $119K -$43.1K -26.6% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $89.8K -$335K -78.9% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $115K -$357K -75.7% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $139K -$379K -73.2% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $162K Dec 31, 2019 10-K 2021-03-11
Q3 2019 $425K Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $472K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $518K Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.